As previously disclosed, on August 29, 2025, the Company entered into an At The Market Offering Agreement (the “Agreement”) with Craig-Hallum Capital Group LLC (the “Sales Agent”) under which the Com…
alid and scientifically supported approach to the treatment of neurological conditions, and accordingly, we expect for competition in the non-implanted space to grow in the future. While many compani…
Reciprocal relationship from ORANY graph: Reciprocal relationship from NRXS graph: Reciprocal relationship from ORANY graph: Reciprocal relationship from NRXS graph: alid and scientifically supported…
NeurAxis, Inc. Debt Obligations
Instrument
Description
Confidence
Evidence
NRXS-DEBT-11375
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2024-12-31.
NRXS-DEBT
Debt stack $426,610
90%
Market cache reports total debt of $426,610.
NRXS-DEBT-11374
Warrants outstanding: 0.01
90%
xbrl warrant detail from xbrl 2025-12-31.
NeurAxis, Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for NeurAxis, Inc..
NeurAxis, Inc. Ownership
Holder
Name
Confidence
Evidence
NRXS-OWNER-VANGUARD-CAPITAL-MANAGEMENT-LLC
VANGUARD CAPITAL MANAGEMENT LLC
90%
13F overlay lists VANGUARD CAPITAL MANAGEMENT LLC as top holder; 26 tracked holders.